Literature DB >> 22522387

Association between single-nucleotide polymorphisms on chromosome 1p22 and 20q12 and nonsyndromic cleft lip with or without cleft palate: new data in Han Chinese and meta-analysis.

Enmin Huang1, Hongqiu Cheng, Mingyan Xu, Shenyou Shu, Shijie Tang.   

Abstract

BACKGROUND: Nonsyndromic cleft lip with or without cleft palate (NSCL/P) is a common congenital malformation associated with genetic and environmental risk factors. A recent genome-wide association study identified two novel susceptibility loci on chromosomes 1p22 and 20q12; however, conflicting results, especially for 1p22, have been reported in Han Chinese population. The aims of this study were to replicate this association with risk of NSCL/P in the southern Han Chinese population and to discern the effect of these loci by a meta-analysis.
METHODS: To this end, 305 patients with NSCL/P, 356 phenotypically normal controls, and an additional 176 case-parent trios were recruited. Four of the previously associated single nucleotide polymorphisms (SNPs) were genotyped by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Furthermore, two published datasets were combined with the present results to determine the precise roles of the loci.
RESULTS: SNPs (rs6072081, rs13041247, and rs6102085) on 20q12 were found to be strongly associated with NSCL/P (Bonferroni-corrected and χ(2) test; p values < 0.05). Subsequent analysis of the case-parent trio provided similar results. However, neither the association study nor the trio analysis supported a causative role for SNP rs560426 on 1p22 in NSCL/P susceptibility. Stratified meta- analysis combining Chinese samples supported our findings.
CONCLUSIONS: This cross-validation study confirmed the previous findings that SNPs in 20q12 are associated with NSCL/P in Han Chinese population. We further conclude that rs560426 on 1p22 might not have a major influence on susceptibility to NSCL/P in southern Han Chinese, but future studies with other Han Chinese populations are needed.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22522387     DOI: 10.1002/bdra.23013

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  6 in total

1.  Polymorphic Variants of V-Maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog B (rs13041247 and rs11696257) and Risk of Non-Syndromic Cleft Lip/Palate: Systematic Review and Meta-Analysis.

Authors:  Mohammad Moslem Imani; Pia Lopez-Jornet; Eduardo Pons-Fuster López; Masoud Sadeghi
Journal:  Int J Environ Res Public Health       Date:  2019-08-05       Impact factor: 3.390

2.  Association between 20q12 rs13041247 polymorphism and risk of nonsyndromic cleft lip with or without cleft palate: a meta-analysis.

Authors:  Liheng Huang; Xinglong Liang; Yangzhan Ou; Shijie Tang; Yunpu He
Journal:  BMC Oral Health       Date:  2020-02-04       Impact factor: 2.757

Review 3.  Polymorphisms of ATP-Binding Cassette, Sub-Family A, Member 4 (rs560426 and rs481931) and Non-Syndromic Cleft Lip/Palate: A Meta-Analysis.

Authors:  Mohammad Moslem Imani; Masoud Sadeghi; Santosh Kumar Tadakamadla; Annette Brühl; Dena Sadeghi Bahmani; Mohammad Taheri; Serge Brand
Journal:  Life (Basel)       Date:  2021-01-15

4.  Environmental and Genetic Risk Factors of Congenital Anomalies: an Umbrella Review of Systematic Reviews and Meta-Analyses.

Authors:  Kyung Shin Lee; Yoon Jung Choi; Jinwoo Cho; Hyunji Lee; Heejin Lee; Soo Jin Park; Joong Shin Park; Yun Chul Hong
Journal:  J Korean Med Sci       Date:  2021-07-19       Impact factor: 2.153

5.  Risk prediction models for oral clefts allowing for phenotypic heterogeneity.

Authors:  Yalu Wen; Qing Lu
Journal:  Front Genet       Date:  2015-08-13       Impact factor: 4.599

6.  Association of single nucleotide polymorphisms at 20q12 with nonsyndromic cleft lip with or without cleft palate in a Southern Chinese Han cohort.

Authors:  Yunpu He; Liheng Huang; Yuqian Zheng; Jian-Huan Chen; Shijie Tang
Journal:  Mol Genet Genomic Med       Date:  2019-11-11       Impact factor: 2.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.